Faruqi & Faruqi reminds Humacyte investors of pending class action lawsuit

Investors in Humacyte are being reminded of an upcoming deadline for a class action lawsuit. The lead plaintiff has until January 17, 2025, to take action.

Humacyte investors should be aware of this important deadline. The class action lawsuit is moving forward, and it’s important for investors to stay informed.

It’s crucial for investors to understand their rights and options in this situation. The deadline is approaching, so investors should take action soon.

If you are a Humacyte investor, make sure you are aware of the pending class action lawsuit. The deadline for the lead plaintiff is January 17, 2025.

Stay informed and take action before the deadline. It’s important to protect your rights as an investor in this situation.